Cargando…
Editorial Comment to Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
Autor principal: | Tomisaki, Ikko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249656/ https://www.ncbi.nlm.nih.gov/pubmed/35795133 http://dx.doi.org/10.1002/iju5.12453 |
Ejemplares similares
-
Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium laser enucleation of the prostate
por: Nakiri, Makoto, et al.
Publicado: (2022) -
Editorial Comment to A conservative treatment for eosinophilic cystitis
por: Tomisaki, Ikko
Publicado: (2022) -
Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Tomisaki, Ikko
Publicado: (2019) -
Current surgical techniques of enucleation in holmium laser enucleation of the prostate
por: Oh, Seung-June
Publicado: (2019) -
Evolution and success of holmium laser enucleation of the prostate
por: Krambeck, Amy E.
Publicado: (2010)